Options of treatment in junior people with patellar tendinopathy Musculoskeletal Diseases
Conditions
Interventions
This study is designed as a single-blind randomized controlled trial. The objective is to assess the effectiveness of heavy slow resistance (HSR) therapy in combination with high-dose therapeutic ultr
Sponsors
Wuhan Sports University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects with a Victorian Institute of Sport Assessment-Patella (VISA-P) questionnaire score of 6 mm) and/or increased intra-tendinous Doppler flow
Exclusion criteria
Exclusion criteria: 1. Duration of pain less than three months 2. Acute knee or patellar tendon injury with a history of knee surgery in the past year 3. Presence of inflammatory arthropathy with the use of potentially affecting patellar tendon medications (e.g., quinolones) in the past year 4. Use of corticosteroids for topical injections in the past month 5. History of past patellar tendon rupture 6. Inability to perform an exercise program or participate in other treatment programs 7. Inability to perform an exercise program or participate in other treatment programs, and other coexisting lesions identified by physical examination or ultrasound/MRI 8. Exercise program, or participation in another treatment program, physical examination or ultrasound/MRI findings of other coexisting knee pathology 9. Inability to undergo high-energy dose ultrasound therapy or indications that ultrasound is contraindicated such as (active tuberculosis, bleeding tendency, severe cardiac disease, malignant tumors, venous thrombosis, and pregnant women)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Improvement in subjects with patellar tendinopathy (PT) measured using the Victorian Institute of Sport Assessment Scale for Patellar Tendinopathy (VISA-P) questionnaire scores at baseline, 8 weeks and 16 weeks 2. Pain in subjects with PT measured using Visual Analogue Score (VAS) scores at baseline and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures are assessed at baseline and 8 weeks: 1. Improvement in balance in subjects with patellar tendinopathy (PT) measured using the Y-Balance Test (YBT) 2. Quadriceps flexibility measured using the Modified Tomas Test 3. Improvement in strength and jumping ability measured using appropriate testing equipment 4. Patellar tendon thickness and blood flow in the tendon measured using a musculoskeletal ultrasound detector | — |
Countries
China
Contacts
Public Contactliufeng Xiao
Outcome results
None listed